Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Selective estrogen receptor modulators: clinical spectrum.

× No keyword cloud information.

29 in total

1. Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study.

Authors: Yakir Segev; Barry Rosen; Jan Lubinski; Jacek Gronwald; Henry T Lynch; Pal Moller; Charmaine Kim-Sing; Parviz Ghadirian; Beth Karlan; Charis Eng; Dawna Gilchrist; Susan L Neuhausen; Andrea Eisen; Eitan Friedman; David Euhus; Sun Ping; Steven A Narod
Journal: Fam Cancer Date: 2015-09 Impact factor: 2.375

2. Chemical modification modulates estrogenic activity, oxidative reactivity, and metabolic stability in 4'F-DMA, a new benzothiophene selective estrogen receptor modulator.

Authors: Hong Liu; Judy L Bolton; Gregory R J Thatcher
Journal: Chem Res Toxicol Date: 2006-06 Impact factor: 3.739

3. Lysine-specific histone demethylase 1 inhibitors control breast cancer proliferation in ERα-dependent and -independent manners.

Authors: Julie A Pollock; Michelle D Larrea; Jeff S Jasper; Donald P McDonnell; Dewey G McCafferty
Journal: ACS Chem Biol Date: 2012-05-10 Impact factor: 5.100

4. Is there a future for selective estrogen-receptor modulators in osteoporosis?

Authors: Roberto C Güerri-Fernández; Adolfo Diez-Perez
Journal: Ther Adv Musculoskelet Dis Date: 2012-04 Impact factor: 5.346

5. Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression.

Authors: N K Shevde; A C Bendixen; K M Dienger; J W Pike
Journal: Proc Natl Acad Sci U S A Date: 2000-07-05 Impact factor: 11.205

6. Effects of genistein on vertebral trabecular bone microstructure, bone mineral density, microcracks, osteocyte density, and bone strength in ovariectomized rats.

Authors: Ruchun Dai; Yulin Ma; Zhifeng Sheng; Yan Jin; Yuhai Zhang; Lingna Fang; Huijie Fan; Eryuan Liao
Journal: J Bone Miner Metab Date: 2008-07-04 Impact factor: 2.626

7. Tamoxifen is an estrogen antagonist on gonadotropin secretion and responsiveness of the hypothalamic-pituitary- adrenal axis in female monkeys.

Authors: M E Wilson; D Mook; F Graves; J Felger; I F Bielsky; K Wallen
Journal: Endocrine Date: 2003-12 Impact factor: 3.633

8. Effect of brimonidine, an α2 adrenergic agonist, on human meibomian gland epithelial cells.

Authors: Xi Han; Yang Liu; Wendy R Kam; David A Sullivan
Journal: Exp Eye Res Date: 2018-02-13 Impact factor: 3.467

9. Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial.

Authors: Jean Yves Reginster; Dieter Felsenberg; Imre Pavo; Jan Stepan; Juraj Payer; Heinrich Resch; Claus C Glüer; Dieter Mühlenbacher; Deborah Quail; Henry Schmitt; Thomas Nickelsen
Journal: Osteoporos Int Date: 2003-06-19 Impact factor: 4.507

10. Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer.

Authors: Azael Freites-Martinez; Jerry Shapiro; Donald Chan; Monica Fornier; Shanu Modi; Devika Gajria; Stephen Dusza; Shari Goldfarb; Mario E Lacouture
Journal: JAMA Dermatol Date: 2018-06-01 Impact factor: 10.282